Progetti in evidenza
Fondo Europeo Pesca(388 visite)
Fondazione Veronesi(Link esterno)
MFAG Grant(957 visite)
Inhibition of Bone Marrow-Derived Mesenchymal Stem Cells Homing Towards Triple-Negative Breast Cancer Microenvironment Using an Anti-PDGFRbeta Aptamer (229 visite) (PDF 54 visite)
Theranostics (ISSN: 1838-7640electronic, 1838-7640linking), 2017 Aug 22; 7(14): 3595-3607.
Tipo di articolo: Journal Article,
Impact factor: 8.766
Impact factor a 5 anni: 9.222
Parole chiave: Bone Marrow-Derived Mesenchymal Stem Cells, Aptamer, Platelet-Derived Growth Factor Receptor Beta, Triple-Negative Breast Cancer.,
Url: Non disponibile.
Bone marrow-derived mesenchymal stem cells (BM-MSCs) are shown to participate in tumor progression by establishing a favorable tumor microenvironment (TME) that promote metastasis through a cytokine networks. However, the mechanism of homing and recruitment of BM-MSCs into tumors and their potential role in malignant tissue progression is poorly understood and controversial. Here we show that BM-MSCs increase aggressiveness of triple-negative breast cancer (TNBC) cell lines evaluated as capability to migrate, invade and acquire stemness markers. Importantly, we demonstrate that the treatment of BM-MSCs with a nuclease-resistant RNA aptamer against platelet-derived growth factor receptor beta (PDGFRbeta) causes the inhibition of receptor-dependent signaling pathways thus drastically hampering BM-MSC recruitment towards TNBC cell lines and BM-MSCs trans-differentiation into carcinoma-associated fibroblast (CAF)-like cells. Moreover, in vivo molecular imaging analysis demonstrated the aptamer ability to prevent BM-MSCs homing to TNBC xenografts. Collectively, our results indicate the anti-PDGFRbeta aptamer as a novel therapeutic tool to interfere with BM-MSCs attraction to TNBC providing the rationale to further explore the aptamer in more complex pre-clinical settings.
*** IBB - CNR ***
Istituto per l'Endocrinologia e l'Oncologia Sperimentale "G. Salvatore", CNR, Naples, Italy., Istituto di Biostrutture e Bioimmagini-CNR, Naples, Italy., Ceinge, Advanced Biotechnology, Scarl, Naples, Italy., Dipartimento di Scienze Biomediche Avanzate, Universita degli Studi di Napoli "Federico II", Naples, Italy., IRCCS SDN, Naples, Italy.,
Esporta in BibTeX Esporta in EndNote
Ultima modifica di Gennaro Angrisano in data Monday 18 September 2017, 12:20:11
229 visite. Ultima visita in data Monday 23 April 2018, 8:48:43
Nessun bando in corso.
Archivio Concorsi>>> (858 visite)
Nessun evento in programma.
Archivio Eventi>>> (536 visite)